Failure to Reassess and Document Long-Term Antibiotic Use
Summary
The facility failed to ensure antibiotic use was supported by ongoing reassessment and documented justification for a resident who was receiving levofloxacin for extended or long-term use. The resident was admitted with diagnoses including palliative care, anxiety, atrial fibrillation, and a chronic nonhealing left knee and thigh wound with abscess that had been surgically drained during a hospitalization in April 2025. The hospital discharge summary dated 4/9/25 indicated treatment for a left knee/distal thigh deep abscess with incision and drainage on 4/1/25, and the discharge plan from Infectious Disease included levofloxacin 750 mg every 48 hours through 4/21/25. Review of the resident’s electronic record showed levofloxacin 750 mg by mouth every 48 hours was ordered again on 6/26/25, two months after the last hospitalization, without clinical justification or supporting notes in the medical record. An orthopedic note dated 7/18/25 stated the resident was three months post I&D of the deep abscess and was continued on suppressive therapy with levofloxacin 250 mg every 48 hours for chronic use, which was increased to 750 mg every 48 hours by the facility’s primary MD. The resident was later placed on palliative care with comfort measures while continuing the antibiotic. During record review and interviews, staff acknowledged there were no subsequent wound cultures obtained to reassess continued levofloxacin use and no later infection screenings after the 7/17/25 infection screening evaluation to determine whether the resident still had an active infection or needed the antibiotic. A pharmacist recommended updating the order with a stop date or documenting the reason for indefinite continuation, and the handwritten response indicated the resident would continue levofloxacin per family request. The DON stated there was no documented education for the family regarding the risks and benefits of prolonged antibiotic use, and the MD stated the resident had been restarted on full-dose levofloxacin for long-term use without documented clinical justification or progress notes addressing effectiveness, with no follow-up from Infectious Disease to determine whether continuation was appropriate.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.